BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35294378)

  • 21. Barriers and facilitators to hepatitis B birth dose vaccination: Perspectives from healthcare providers and pregnant women accessing antenatal care in Nigeria.
    Freeland C; Kanu F; Mohammed Y; Nwokoro UU; Sandhu H; Ikwe H; Uba B; Asekun A; Akataobi C; Adewole A; Fadahunsi R; Wisdom M; Akudo OL; Ugbenyo G; Simple E; Waziri N; Vasumu JJ; Bahuli AU; Bashir SS; Isa A; Ugwu GO; Obi EI; Binta H; Bassey BO; Shuaib F; Bolu O; Tohme RA
    PLOS Glob Public Health; 2023; 3(6):e0001332. PubMed ID: 37289735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of newborn hepatitis B vaccination--worldwide, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1249-52. PubMed ID: 19023261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coverage, inequity and predictors of hepatitis B birth vaccination in Myanmar from 2011-2016: results from a national survey.
    Anderson ACT; Richards A; Delucchi K; Khalili M
    BMC Health Serv Res; 2022 Apr; 22(1):516. PubMed ID: 35436953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementing the birth dose of hepatitis B vaccine in rural Indonesia.
    Creati M; Saleh A; Ruff TA; Stewart T; Otto B; Sutanto A; Clements CJ
    Vaccine; 2007 Aug; 25(32):5985-93. PubMed ID: 17604881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Social and behavioral determinants of attitudes towards and practices of hepatitis B vaccine birth dose in Vietnam.
    Thanh Thi Le X; Ishizumi A; Thi Thu Nguyen H; Thi Duong H; Thi Thanh Dang H; Manh Do C; Thi Pham Q; Thi Le H; Iijima M; Tohme RA; Patel P; Abad N
    Vaccine; 2020 Dec; 38(52):8343-8350. PubMed ID: 33221065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The coverage of hepatitis B birth dose vaccination in Nigeria: Does the place of delivery matter?
    Olakunde BO; Adeyinka DA; Olakunde OA; Ogundipe T; Oladunni F; Ezeanolue EE
    Trans R Soc Trop Med Hyg; 2022 Apr; 116(4):359-368. PubMed ID: 34453162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B vaccine stored outside the cold chain setting: a pilot study in rural Lao PDR.
    Kolwaite AR; Xeuatvongsa A; Ramirez-Gonzalez A; Wannemuehler K; Vongxay V; Vilayvone V; Hennessey K; Patel MK
    Vaccine; 2016 Jun; 34(28):3324-30. PubMed ID: 27040399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An approach for preparing and responding to adverse events following immunization reported after hepatitis B vaccine birth dose administration.
    Gidudu JF; Shaum A; Habersaat K; Wilhelm E; Woodring J; Mast E; Zuber P; Amarasinghe A; Nelson N; Kabore H; Abad N; Tohme RA
    Vaccine; 2020 Nov; 38(49):7728-7740. PubMed ID: 31337590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coverage and Timeliness of Birth Dose Vaccination in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
    Bassoum O; Kimura M; Tal Dia A; Lemoine M; Shimakawa Y
    Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32545322
    [No Abstract]   [Full Text] [Related]  

  • 30. Using intervention mapping to develop an implementation strategy to improve timely uptake of streamlined birth-dose vaccines in the Democratic Republic of the Congo.
    Boisson-Walsh A; Fried B; Shea CM; Ngimbi P; Mbonze N; Tabala M; Kashamuka MM; Babakazo P; Yotebieng M; Thompson P
    PLOS Glob Public Health; 2024; 4(1):e0002641. PubMed ID: 38271398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study.
    Thompson P; Morgan CE; Ngimbi P; Mwandagalirwa K; Ravelomanana NLR; Tabala M; Fathy M; Kawende B; Muwonga J; Misingi P; Mbendi C; Luhata C; Jhaveri R; Cloherty G; Kaba D; Yotebieng M; Parr JB
    Lancet Glob Health; 2021 Nov; 9(11):e1600-e1609. PubMed ID: 34416175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
    Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
    Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barriers to Timely Administration of Hepatitis B Birth Dose Vaccine to Neonates of Mothers With Hepatitis B in Ghana: Midwives' Perspectives.
    Adjei CA; Suglo D; Ahenkorah AY; MacDonald SE; Richter S
    SAGE Open Nurs; 2023; 9():23779608231177547. PubMed ID: 37261100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving hepatitis B birth dose in rural Lao People's Democratic Republic through the use of mobile phones to facilitate communication.
    Xeuatvongsa A; Datta SS; Moturi E; Wannemuehler K; Philakong P; Vongxay V; Vilayvone V; Patel MK
    Vaccine; 2016 Nov; 34(47):5777-5784. PubMed ID: 27742222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of hepatitis B mother-to-child transmission in Namibia: A cost-effectiveness analysis.
    Tamandjou Tchuem CR; Andersson MI; Wiysonge CS; Mufenda J; Preiser W; Cleary S
    Vaccine; 2021 May; 39(23):3141-3151. PubMed ID: 33962836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B vaccine birth dose coverage correlates worldwide with rates of institutional deliveries and skilled attendance at birth.
    Allison RD; Patel MK; Tohme RA
    Vaccine; 2017 Jul; 35(33):4094-4098. PubMed ID: 28668571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of storing hepatitis B vaccine outside the cold chain in the Solomon Islands: Identifying opportunities and barriers to implementation.
    Breakwell L; Anga J; Dadari I; Sadr-Azodi N; Ogaoga D; Patel M
    Vaccine; 2017 May; 35(21):2770-2774. PubMed ID: 28431814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in China.
    Yu W; Liu D; Zheng J; Liu Y; An Z; Rodewald L; Zhang G; Su Q; Li K; Xu D; Wang F; Yuan P; Xia W; Ning G; Zheng H; Chu Y; Cui J; Duan M; Hao L; Zhou Y; Wu Z; Zhang X; Cui F; Li L; Wang H
    Int J Epidemiol; 2016 Apr; 45(2):441-9. PubMed ID: 27174834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation.
    Cui F; Luo H; Wang F; Zheng H; Gong X; Chen Y; Wu Z; Miao N; Kane M; Hennessey K; Hadler SC; Hutin YJ; Liang X; Yang W
    Vaccine; 2013 Dec; 31 Suppl 9():J36-42. PubMed ID: 24331019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A decision analytic model for prevention of hepatitis B virus infection in Sub-Saharan Africa using birth-dose vaccination.
    Anderson S; Harper LM; Dionne-Odom J; Halle-Ekane G; Tita ATN
    Int J Gynaecol Obstet; 2018 Apr; 141(1):126-132. PubMed ID: 29315536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.